Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Clin Immunol. 2016 Jan 28;164:85–94. doi: 10.1016/j.clim.2016.01.015

Figure 2. B lymphocytes are reduced in spleen and cLNs of BAFFR-Fc and BAFF-Fc/anti-CXCL13 treated mice.

Figure 2

Spleens and cLNs were isolated from animals treated with either I.C., BAFFR-Fc, or BAFFR-Fc/anti-CXCL13. B220+ B cells from (A) spleen and (B) cLN were gated on and examined for expression of CD23 and CD21/35. I.C. = isotype control. Significance was determined using Mann-Whitney test. Mean and SEM and shown (**p < 0.01).